TY - JOUR
T1 - Effects of laparoscopic Roux-en-Y gastric bypass on bone mineral density and markers of bone turnover
AU - Obinwanne, Kosisochi M.
AU - Riess, Kevin P.
AU - Kallies, Kara J.
AU - Mathiason, Michelle A.
AU - Manske, Brian R.
N1 - Publisher Copyright:
© 2014 American Society for Metabolic and Bariatric Surgery. All rights reserved.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Background Despite multiple beneficial effects of weight loss after laparoscopic Roux-en-Y gastric bypass (LRYGB), the influence on bone mineral density (BMD) remains largely unknown. Our objective was to evaluate the changes in BMD and serum/urine bone markers after LRYGB.Methods Thirty-four women undergoing LRYGB were prospectively enrolled and underwent bone densitometry and serum/urine analysis preoperatively and 1 year postoperative. Changes ≥.025 g/cm2 in hip, femoral neck, and spine BMD and decreases>2% in total BMD were considered significant. Statistical analysis included paired t tests and McNemar's test.Results Mean age was 44.6 years. Body mass index at the preoperative and 1-year postoperative intervals were 46.7 and 29.6 kg/m2, respectively. Mean hip, femoral neck, and spine (L1-L4) BMD was 1.191 versus 1.087 g/cm2 (P<.001), 1.105 versus 1.032 g/cm2 (P<.001), and 1.323 versus 1.277 g/cm2 (P<.001) at the preoperative and 1 year postoperative intervals, respectively. Mean total BMD decreased from 1.328 preoperatively to 1.251 g/cm2 at 1 year postoperative (P<.001). The decreases in BMD were 5.8%, 6.5%, 3.5%, and 8.8% for hip, femoral neck, spine (L1-L4) and total BMD from preoperative to 1 year postoperative. The proportion of patients with low vitamin D levels decreased from 55% preoperatively to 21% at 1 year postoperative (P =.004). Elevated osteocalcin and bone alkaline phosphatase was observed in 4% and 63% (P<.001), and 14% and 41% (P =.011) of patients preoperatively and at 1 year postoperative, respectively.Conclusion BMD and bone markers changed significantly after LRYGB. Current recommendations for supplementation in post-LRYGB women may need to be reevaluated.
AB - Background Despite multiple beneficial effects of weight loss after laparoscopic Roux-en-Y gastric bypass (LRYGB), the influence on bone mineral density (BMD) remains largely unknown. Our objective was to evaluate the changes in BMD and serum/urine bone markers after LRYGB.Methods Thirty-four women undergoing LRYGB were prospectively enrolled and underwent bone densitometry and serum/urine analysis preoperatively and 1 year postoperative. Changes ≥.025 g/cm2 in hip, femoral neck, and spine BMD and decreases>2% in total BMD were considered significant. Statistical analysis included paired t tests and McNemar's test.Results Mean age was 44.6 years. Body mass index at the preoperative and 1-year postoperative intervals were 46.7 and 29.6 kg/m2, respectively. Mean hip, femoral neck, and spine (L1-L4) BMD was 1.191 versus 1.087 g/cm2 (P<.001), 1.105 versus 1.032 g/cm2 (P<.001), and 1.323 versus 1.277 g/cm2 (P<.001) at the preoperative and 1 year postoperative intervals, respectively. Mean total BMD decreased from 1.328 preoperatively to 1.251 g/cm2 at 1 year postoperative (P<.001). The decreases in BMD were 5.8%, 6.5%, 3.5%, and 8.8% for hip, femoral neck, spine (L1-L4) and total BMD from preoperative to 1 year postoperative. The proportion of patients with low vitamin D levels decreased from 55% preoperatively to 21% at 1 year postoperative (P =.004). Elevated osteocalcin and bone alkaline phosphatase was observed in 4% and 63% (P<.001), and 14% and 41% (P =.011) of patients preoperatively and at 1 year postoperative, respectively.Conclusion BMD and bone markers changed significantly after LRYGB. Current recommendations for supplementation in post-LRYGB women may need to be reevaluated.
KW - Bone density
KW - Bone resorption
KW - Calcium
KW - Gastric bypass
KW - Osteocalcin
KW - Vitamin D
UR - http://www.scopus.com/inward/record.url?scp=84924070483&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84924070483&partnerID=8YFLogxK
U2 - 10.1016/j.soard.2014.06.018
DO - 10.1016/j.soard.2014.06.018
M3 - Article
C2 - 25443074
AN - SCOPUS:84924070483
SN - 1550-7289
VL - 10
SP - 1056
EP - 1062
JO - Surgery for Obesity and Related Diseases
JF - Surgery for Obesity and Related Diseases
IS - 6
ER -